| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.1M | -31.6% |
| Cost of Revenue | $66K | -92.3% |
| Gross Profit | $2.0M | -8.3% |
| R&D Expense | $9.8M | -71.5% |
| SG&A Expense | $21.9M | -39.1% |
| Operating Income | -$29.7M | +56.5% |
| Income Tax | $0 | — |
| Net Income | -$34.9M | +49.3% |
| EPS (Basic) | -$23.19 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.6M | -25.8% |
| Accounts Receivable | $879K | — |
| Current Assets | $4.5M | -57.8% |
| Total Assets | $10.0M | -51.8% |
| Current Liabilities | $15.0M | +35.1% |
| Total Liabilities | $17.8M | +1.7% |
| Stockholders' Equity | -$7.8M | -345.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.6M | +73.1% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $94K | +594.7% |
| Financing Cash Flow | $15.6M | +710.7% |
| Free Cash Flow | -$16.6M | +73.2% |
| -0.3% |
| EPS (Diluted) | -$23.19 | -0.3% |